The mesenteric traction syndrome (MTS) remains, seventeen years after its first designation as a distinct pathologic entity, an aspect of surgical practice that has received limited attention. Apart from its symptomatology, there is mostly speculation about its exact causes and pathophysiologic mechanisms.
Even though full-blown MTS is rather rare, the advent of laparoscopic surgery has indicated that there are different stages of stress associated with open abdominal surgery. Some evidence points to the involvement of mast cell derived vasoactive mediators and suggests possible pharmacologic management.
DudaD.LorenzW.CelikI., 2002. Histamine release in mesenteric traction syndrome during abdominal aortic aneurysm surgery: Prophylaxis with H1 and H2 antihistamines. Inflamm. Res.51:495.
2.
SeelingW.HeinrichH.OettingerW., 1986. The eventration syndrome: Prostacyclin liberation and acute hypoxemia due to eventration of the small intestine. Anaesthesist35:738.
3.
DrippsR.D.EckenhoffJ.E.VandamL.D., 1982. The principles of safe practice. In Introduction to anesthesia. W.B. SaundersPhiladelphia, p. 374.
4.
StruninL.1980. The splanchnic, hepatic and portal circulations. The circulation in anaesthesia. In Applied Physiology and Pharmacology. Prys-RobersC., ed. Blackwell Scientific PublicationsOxford, p. 241.
5.
KaufmanL.1980. Anaesthesia for abdominal surgery. In General Anaesthesia. GrayT.C.UttingJ.E.NunnJ.F., ed. ButterworthsLondon, p. 1431.
6.
BatchelderB.M.CoopermanL.H., 1975. Effects of anesthetics on splanchnic circulation and metabolism. Surg. Clin. North. Am.55:787.
7.
SeltzerJ.L.RitterD.E.StarsnicM.A.MarrA.T., 1985. The hemodynamic response to traction on the abdominal mesentery. Anesthesiology63:96.
8.
GottliebA.SkrinskaV.A.O'HaraP.BoutrosA.R.MeliaM.BeckG.J., 1989. The role of prostacyclin in the mesenteric traction syndrome during anesthesia for abdominal aortic reconstructive surgery. Ann. Surg.209:363.
9.
SeltzerJ.L.GoldbergM.E.LarijaniG.E.RitterD.E.StarsnicM.A.StahlG.L.LeferA.M., 1988. Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology68:514.
10.
BrinkmannA.WolfC.F.BergerD.KneitingerE.NeumeisterB.BuchlerM.RadermacherP.SeelingW.GeorgieffM., 1996. Perioperative endotoxemia and bacterial translocation during major abdominal surgery: Evidence for the protective effect of endogenous prostacyclin?Crit. Care Med. 24:1293.
11.
KoyamaK.KanekoI.MoriK., 1995. The effect of indomethacin suppository in preventing mesenteric traction syndrome. Masui44:1131.
12.
MossJ.1995. Muscle relaxants and histamine release. Acta Anaesthesiol. Scand.106(S):7.
13.
LorenzW.DudaD.DickW.SitterH.DoenickeA., 1994. Incidence and clinical importance of perioperative histamine release: Randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg. Lancet343:933.
14.
AkerstromG.LisanderB., 1994. Antihistaminergic pretreatment prevents tissue extravasation of albumin from intra-abdominal trauma in rats. Acta Anaesthesiol. Scand.38:569.
15.
CutzE.ChanW.TrackN.S.GothA.SaidS.I., 1978. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature275:661.
16.
BoesigerJ.TsaiM.MaurerM.YamaguchiM.BrownL.F.ClaffeyK.P.DvorakH.F.GalliS.J., 1998. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fce reptor I expression. J. Exp. Med.188:1135.
17.
GrutzkauA.Kruger-KrasagakesS.BaumeisterH.SchwarzC.KogelH.WelkerP.LippertU.HenzB.M.MollerA., 1998. Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206. Mol. Biol. Cell9:875.
18.
BuenoL.FargeasM.J.TheodorouV.FioramontiJ., 1991. Involvement of 5-hydroxytryptamine in the intestinal motor disturbances induced by mast cell degranulation in rats. Eur. J. Pharmacol.192:263.
19.
TheoharidesT.C.BondyP.K.TsakalosN.D.AskenaseP.W., 1982. Differential release of serotonin and histamine from mast cells. Nature297:229.
20.
Kandere-GrzybowskaK.LetourneauR.BoucherW.BeryJ.KempurajD.PoplawskiS.AthanassiouA.TheoharidesT.C., 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol.171:4830.
21.
EnerbäckL.1963. Serotonin in human mast cells. Nature117:610.
22.
TheoharidesT.C.LetourneauR.PatraP.HesseL.PangX.BoucherW.MompointC.HarringtonB., 1999. Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans. Dig. Dis. Sci.44(S):87.
23.
WedemeyerJ.TsaiM.GalliS.J., 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol.12:624.
24.
MaroneG.GalliS.J.KitamuraY., 2002. Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. Trends Immunol. 23:425.
25.
TheoharidesT.C.CochraneD.E., 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol.146:1.
26.
KempurajD.FrydasS.KaragouniE.HatzistilianouM.BoscoloP.FerroF.Di GiannantonioM.ContiC.M.V.MerlittiD.DoyleR.PetrarcaC.CastellaniM.L.TheoharidesT.C., Cytokines and the brain. 2004. Int. J. Immunopathol. Pharmacol.17:229.
27.
HuangS.H.FrydasS.ContiP.KempurajD.BarbacaneR.C.GrilliA.BoucherW.LetourneauR.PapadopoulouN.TheoharidesT.C., 2004. Interleukin-17: A revisited study. Int. J. Immunopathol. Pharmacol.17:1.
28.
KempurajD.MadhappanB.SheeladeviR.NazerM.ChristodoulouS.ReginaldJ.SuthinthirarajanN.NamasivayamA., 2004. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int. J. Immunopathol. Pharmacol.17:57.
AlexandrakisM.G.KyriakouD.S.SeretakisD.BoucherW.LetourneauR.KempurajD.TheoharidesT.C., 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1). Int. J. Immunopathol. Pharmacol.16:43.
31.
EnerbäckL.1965. Mast cells in carcinoid tumours. Distribution, histochemical properties and 5-hydroxytryptamine content. Acta Pathol. Microbiol. Scand.64:491.
32.
KulkeM.H.MayerR.J., 1999. Carcinoid tumors. N. Engl. J. Med.340:858.
33.
PothoulakisC.CastagliuoloI.LaMontJ.T., 1998. Nerves and intestinal mast cells modulate responses to enterotoxins. News Physiol. Sci.13:58.
34.
MaurerM.TheoharidesT.C.GransteinR.D.BischoffS.C.BienenstockJ.HenzB.KovanenP.PiliponskyA.M.KambeN.VliagoftisH.Levi-SchafferF.MetzM.MiyachiY.BefusD.ForsytheP.KitamuraY.GalliS., 2003. What is the physiological function of mast cells?Exp. Dermatol.12:886.
35.
HildebrandtU.KesslerK.PlusczykT.PistoriusG.VollmarB.MengerM.D., 2003. Comparison of surgical stress between laparoscopic and open colonic resections. Surg. Endosc.17:242.
36.
TheoharidesT.C.DonelanJ.M.PapadopireloireN.CaoJ.KempuraynD.ContiP., 2004. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci.25:563.
37.
KempurajD.HuangM.Kandere-GrzybowskaK.BasuS.BoucherW.LetourneauR.AthanasiouA.TheoharidesT.C., 2003. Azelastine inhibits secretion of IL-6, TNF-α and IL-8 as well as NF-κB activation and intracellular calcium ion levels in normal human mast cells. Int. Arch. Allergy. Immunol.132:231.
38.
MiddletonE.Jr.KandaswamiC.TheoharidesT.C., 2000. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev.52:673.
39.
TheoharidesT.C.AlexandrakisM.KempurayD.LytinasM., 2001. Anti-inflammatory actions of flavonoids and structural requirements for new design. Int J. Immonopathol. Pharmacol.14:119.